-
EU lockdowns saved more than 3m lives, research indicates
pharmatimes
June 09, 2020
Millions of lives have been saved by non-pharmaceutical interventions to the coronavirus pandemic such as nationwide large-scale lockdowns, suggests a new analysis by researchers from Imperial College London.
-
Arbor Vita Launches Open Platform COVID-19 Antibody Test Expanding Access To Higher Quality Diagnostics
prnewswire
June 09, 2020
Arbor Vita announced the availability of its CoVisa? IgG ELISA-based test for antibodies associated with the novel coronavirus (COVID-19).
-
Nobel Prize-Winning Scientist Explains Why New Study in New England Journal of Medicine May Point To Nitric Oxide as Successful Treatment For COVID-19
prnewswire
June 09, 2020
Although the recent study "Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19" by Ackermann, et al does not include any mention of nitric oxide, many of the world's leading researchers and scientists agree that ...
-
Lilly Announces Start of a Phase 1 Study for its Second Potential COVID-19 Antibody Treatment
prnewswire
June 09, 2020
Eli Lilly and Company announced its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment designed to fight COVID-19.
-
Phosphorus Announces FDA Approval Of At-Home Saliva Test For COVID-19
prnewswire
June 09, 2020
At-Home Saliva Test Gains Federal Approval After Rigorous Round of Validation Studies.
-
Omega Bio-tek Launches a New Viral RNA Extraction Kit for COVID-19 Testing with Production Capacity for 6 Million Tests A Month.
prnewswire
June 09, 2020
Omega Bio-tek, Inc. announces the launch of the Mag-Bind? Viral RNA Xpress Kit for the rapid and reliable isolation of Viral RNA from nasopharyngeal (NP) swab specimens that are dry or in viral transport media (VTM).
-
FDA Updates Q&A Appendix of Medical Products During COVID-19 Public Health Emergency
americanpharmaceuticalreview
June 09, 2020
The U.S. Food and Drug Administration (FDA) added content to the question-and-answer appendix in its guidance titled “Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency.”
-
ImmunoPrecise, Integrated Biotherapeutics, NIH Collaborate to Study Structural Details of Antibodies for COVID-19
americanpharmaceuticalreview
June 09, 2020
Immunoprecise Antibodies announced it is collaborating in a multi-company effort with the laboratory of Dr. Frederick Dyda at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH) ...
-
COVID-19 Update: FDA Shares Antibody Test Performance Data
contractpharma
June 09, 2020
Independently evaluates certain antibody tests, including antibody tests that were not the subject of an EUA or pre-EUA, and those that were under FDA review.
-
Tonix and Fujifilm Enter COVID-19 Vax Deal
contractpharma
June 09, 2020
Collaboration includes development of manufacturing processes and supply of clinical trial material to support Tonix’s development of TNX-1800.